Patents Assigned to Metabolic Soultions Development Company, LLC
  • Thiazolidinedione analogues
    Patent number: 8389556
    Abstract: The present invention relates to methods of using thiazolidinedione analogues of formula I: for treating Alzheimer's disease The terms R1, R2 and R3 are herein defined.
    Type: Grant
    Filed: May 18, 2011
    Date of Patent: March 5, 2013
    Assignee: Metabolic Soultions Development Company, LLC
    Inventors: Gerard R. Colca, Rolf F. Kletzien